Novel oral anticoagulants for venous thromboembolism prophylaxis after total hip or knee replacement: An update on rivaroxaban (Xarelto)

摘要

In 2005, approximately 285,000 individuals underwent tota hip replacement (THR) procedures, and approximately 523,00( individuals had total knee replacement (TKR) procedures ir the U.S. As the population ages, it is estimated that by 203( the demand for these surgeries will increase, and the numbers are expected to grow to 572,000 THR procedures and 3,480,00( TKR procedures annually.